| REGISTERED NUMBER: |
| Unaudited Financial Statements |
| for the Year Ended |
| 28 February 2025 |
| for |
| Axe Ventures Limited |
| REGISTERED NUMBER: |
| Unaudited Financial Statements |
| for the Year Ended |
| 28 February 2025 |
| for |
| Axe Ventures Limited |
| Axe Ventures Limited (Registered number: 13195061) |
| Contents of the Financial Statements |
| for the Year Ended 28 February 2025 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 3 |
| Axe Ventures Limited |
| Company Information |
| for the Year Ended 28 February 2025 |
| DIRECTOR: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| Axe Ventures Limited (Registered number: 13195061) |
| Balance Sheet |
| 28 February 2025 |
| 28.2.25 | 29.2.24 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Investments | 4 |
| CURRENT ASSETS |
| Debtors | 5 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 6 |
| NET CURRENT LIABILITIES | ( |
) | ( |
) |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
( |
) |
( |
) |
| CAPITAL AND RESERVES |
| Called up share capital | 7 |
| Retained earnings | ( |
) | ( |
) |
| SHAREHOLDERS' FUNDS | ( |
) | ( |
) |
| The director acknowledges his responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| The financial statements were approved by the director and authorised for issue on |
| Axe Ventures Limited (Registered number: 13195061) |
| Notes to the Financial Statements |
| for the Year Ended 28 February 2025 |
| 1. | STATUTORY INFORMATION |
| Axe Ventures Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Investments in subsidiaries |
| Investments in subsidiary undertakings are recognised at cost less any provision for impairment. |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was NIL (2024 - NIL). |
| 4. | FIXED ASSET INVESTMENTS |
| Shares in |
| group |
| undertakings |
| £ |
| COST |
| At 1 March 2024 |
| Additions |
| Disposals | ( |
) |
| At 28 February 2025 |
| NET BOOK VALUE |
| At 28 February 2025 |
| At 29 February 2024 |
| 5. | DEBTORS |
| 28.2.25 | 29.2.24 |
| £ | £ |
| Amounts falling due within one year: |
| Amounts owed by group undertakings |
| Axe Ventures Limited (Registered number: 13195061) |
| Notes to the Financial Statements - continued |
| for the Year Ended 28 February 2025 |
| 5. | DEBTORS - continued |
| 28.2.25 | 29.2.24 |
| £ | £ |
| Amounts falling due after more than one year: |
| Amounts owed by group undertakings |
| Aggregate amounts |
| 6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 28.2.25 | 29.2.24 |
| £ | £ |
| Trade creditors |
| Directors' current account | 5,807,700 | 4,306,900 |
| Accruals and deferred income |
| 7. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 28.2.25 | 29.2.24 |
| value: | £ | £ |
| Ordinary A | £1 | 50 | 50 |
| Ordinary B | £1 | 50 | 50 |
| 100 | 100 |
| 8. | RELATED PARTY DISCLOSURES |
| At the period end, included in debtors is a long term loan of £4,000,000 (2024 - £4,000,000 - due within 1 year) to Medicus Health Ltd, a company which Axe Venture Ltd has a controlling interest. From 1 January 2024 interest is payable on the loan at 1% above base rate. Prior to that date, the loan was interest free and repayable on demand. |
| 9. | GOING CONCERN |
| The company relies on the continuing support of its director. The director has agreed to continue to support the company for the foreseeable future as necessary. |